Concepedia

OA10.04 Tarlatamab with a PD-L1 Inhibitor as First-Line Maintenance after Chemo-immunotherapy for ES-SCLC: DeLLphi-303 Phase 1b Study

Shu Ping Lau, M-J. Ahn, Mor Moskovitz, Michael Pogorzelski, Simon Haefliger, K. G. Paulson, Andrew Parkes, Y. Zhang, Anahita Hamidi, Martin Wermke

Journal of Thoracic Oncology · 2024 · 12 citations · 0 references

Open access